Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;111(7):2647-2654.
doi: 10.1111/cas.14500. Epub 2020 Jun 13.

Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer

Affiliations

Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer

Yoshiya Horimoto et al. Cancer Sci. 2020 Jul.

Abstract

The frequency of microsatellite instability (MSI) is reportedly extremely low in breast cancer, despite widespread clinical expectations that many patients would be responsive to immune-checkpoint inhibitors (ICI). Considering that some triple-negative breast cancers (TNBC) responded well to ICI in a clinical trial and that a high density of tumor-infiltrating lymphocytes (TILs) is frequently observed in other cancers with high levels of microsatellite instability (MSI-H), we hypothesized that some TNBC with a high density of TILs would be MSI-H. Medullary carcinoma (MedCa) of the breast, a rare histological type, is characterized by a high density of TILs. Considering that MedCa of the colon is often MSI-H, we suspected that MedCa in breast cancer might also include MSI-H tumors. Therefore, we conducted MSI tests on such breast cancers with a high density of TILs. The MSI status of 63 TIL-high TNBC and 38 MedCa tumors, all from Asian women who had undergone curative surgery, were determined retrospectively. DNA mismatch repair (MMR) proteins and PD-L1 expression were also investigated immunohistochemically. All samples were microsatellite stable, being negative for all microsatellite markers. TIL-high TNBC with low MLH1 protein had higher levels of PD-L1 in stromal immune cells (P = .041). MedCa tumors showed significantly higher PD-L1 expression in immune cells than in TIL-high TNBC (<.001). We found that MSI-H tumors were absent in TIL-high breast cancers. Examination of MMR proteins, not a purpose of Lynch syndrome screening, may merit further studies to yield predictive information for identifying patients who are likely to benefit from ICI.

Keywords: DNA mismatch repair protein; PD-L1; breast cancer; medullary carcinoma; microsatellite instability; tumor-infiltrating lymphocyte.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
Relationships between MMR and PD‐L1 expression. Relationships between MMR and PD‐L1 expression in TC and IC, respectively are shown. A, TIL‐high TN (n = 63). B, MedCa (n = 38). The logistic regression model was employed for evaluation of associations between these 2 parameters as the scales of MMR protein and PD‐L1 expression were continuous and nominal variables, respectively

Similar articles

Cited by

References

    1. Hampel H, Frankel W, Panescu J, et al. Screening for lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer) among endometrial cancer patients. Cancer Res. 2006;66:7810‐7817. - PubMed
    1. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783‐5788. - PMC - PubMed
    1. Hause RJ, Pritchard CC, Shendure J, et al. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22:1342. - PubMed
    1. Bonneville R, Krook MA, Kautto EA, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precision Oncol. 2017;1:1‐15. - PMC - PubMed
    1. Latham A, Srinivasan P, Kemel Y, et al. Microsatellite instability is associated with the presence of lynch syndrome pan‐cancer. J Clin Oncol. 2017;37:286‐295. - PMC - PubMed